Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,389,377
-$1,782,248,746 QoQ
Shares Held
25,158
-99.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,435
of 4,676 holders
Holding Since
Jun 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GQG Partners LLC holds $855,412,874 across 8 Drug Manufacturers - General names. JNJ ranks #5 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,921,614 | $483,554,946 | |
| 2 | NVS |
Novartis AG
|
2,151,131 | $337,125,250 | |
| 3 | AZN |
Astrazeneca PLC
|
45,569 | $8,640,793 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,092 | $6,822,322 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
25,158 | $6,389,377 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
96,264 | $5,546,731 | |
| 7 | SNY |
Sanofi
|
97,640 | $4,165,322 | |
| 8 | PFE |
Pfizer Inc
|
131,567 | $3,168,133 |
All Filings in JNJ
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,389,377 | 25,158 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,788,638,123 | 7,317,289 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,604,331,448 | 7,752,266 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,119,487,898 | 6,037,579 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $7,536,226 | 49,337 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $270,485 | 1,631 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $236,453 | 1,635 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $243,517,838 | 1,502,640 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,165,666 | 55,868 | Shares | Sole | 2024-08-12 | |
| 2022-12-31 | $9,101,537 | 51,523 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $189,196,364 | 1,158,156 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,166,191,707 | 6,569,724 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,152,307,102 | 6,501,761 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $676,476,299 | 3,954,383 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $52,803,878 | 326,959 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $1,076,905 | 6,537 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $70,469,993 | 428,780 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $35,090,546 | 222,967 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,595,695 | 10,718 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,435,410 | 10,207 | Shares | Sole | 2020-08-19 | |
| No filing history on record for this holder in this stock. | ||||||